Metformin decreases the incidence of ovarian hyperstimulation syndrome: an experimental study

@inproceedings{Elia2013MetforminDT,
  title={Metformin decreases the incidence of ovarian hyperstimulation syndrome: an experimental study},
  author={Evelin Mariel Elia and Ramiro Quintana and Carlos Carrere and Mar{\'i}a Victoria Bazzano and Gast{\'o}n J Rey-Valzacchi and Dante Agust{\'i}n Paz and Mar{\'i}a Carolina Pustovrh},
  booktitle={Journal of ovarian research},
  year={2013}
}
BACKGROUND In assisted reproduction cycles, gonadotropins are administered to obtain a greater number of oocytes. A majority of patients do not have an adverse response; however, approximately 3-6% develop ovarian hyperstimulation syndrome (OHSS). Metformin reduces the risk of OHSS but little is known about the possible effects and mechanisms of action involved. OBJECTIVE To evaluate whether metformin attenuates some of the ovarian adverse effects caused by OHSS and to study the mechanisms… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 53 references

Effects of metformin on gonadotropin-induced ovulation in women with polycystic ovary syndrome

V De Leo, A la Marca, A Ditto, G Morgante, A Cianci
Fertil Steril • 1999
View 3 Excerpts
Highly Influenced

The effectiveness of metformin ovulation induction treatment in patients with PCOS: a systematic review and meta-analysis.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology • 2012
View 1 Excerpt

Similar Papers

Loading similar papers…